[1]
Mastorino, L. et al. 2022. Risk of Reactivation of Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: A Retrospective Cohort from a Tertiary Care Centre in Northern Italy. Acta Dermato-Venereologica. 102, (Nov. 2022), adv00821. DOI:https://doi.org/10.2340/actadv.v102.1982.